Trovagene Announces First Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Piper Jaffray Cuts Price Target on Trovagene (TROV) Following 1Q Miss
May 11, 2016 8:06 AM EDTPiper Jaffray maintained a Neutral rating on TrovaGene (NASDAQ: TROV), and cut the price target to $5.00 (from $8.00), following the company's 1Q earnings report. Trovagene reported revenue of $120K, well below the Street's ~$280K estimate. Adjusted EPS of ($0.36) was $0.07 below the Street estimate of ($0.29).
Analyst... More
Trovagene (TROV) Misses Q1 EPS by 7c
May 10, 2016 4:53 PM EDTTrovagene (NASDAQ: TROV) reported Q1 EPS of ($0.36), $0.07 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $120 thousand versus the consensus estimate of $260 thousand.
For earnings history and earnings-related data on Trovagene (TROV) click here.
... More